{
    "Trade/Device Name(s)": [
        "EUROIMMUN Anti-M2-3E ELISA (IgG)",
        "Anti-M2-3E ELISA (IgG)"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K092736",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052262"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DBM"
    ],
    "Summary Letter Date": "July 22, 2010",
    "Summary Letter Received Date": "July 30, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5090"
    ],
    "Regulation Name(s)": [
        "Antimitochondrial antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-M2-3E autoantibodies",
        "IgG class autoantibodies against mitochondrial antigens M2"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Microwell plate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (ELISA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN Anti-M2-3E ELISA (IgG) qualitative/semi-quantitative test for anti-mitochondrial IgG autoantibodies in serum/plasma",
    "Indications for Use Summary": "Qualitative or semi-quantitative determination of IgG class autoantibodies against mitochondrial antigens M2 in human serum and plasma as an aid in the diagnosis of primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis, for prescription use.",
    "fda_folder": "Immunology"
}